Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
93.85%
Operating Margin
67.81%
Net Margin
57.02%
Efficiency Metrics
Revenue per Expense Ratio
1.61
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
67.81%
Income Tax Rate
0.27%
EPS
5.0800000000
Balance Sheet Analysis
Current Ratio
2.24
Cash Ratio
58.55
Working Capital
$457.96K
Debt to Equity
0.33
Debt to Assets
23.15%
Equity Ratio
69.41%
Cash Flow Analysis
Operating Cash Flow Ratio
18.47%
Free Cash Flow Ratio
18.47%
CapEx to Revenue
0.00%
Dividends Paid
$30.31M
Stock Buybacks
$3.73M
Total Shareholder Returns
$34.04M
Cash Position Change
104,790,400.0%
Key Takeaways (2023 FY)
Revenue declined by 23.969002712194%, indicating potential market challenges
Increased dividend payments by 22.93%
Detailed Growth Metrics
Core Performance
Revenue
-23.97%
Net Income
-55.63%
EPS
-55.16%
Operating Income
-48.27%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
87.99%
Operating Cash Flow
634.04%
Free Cash Flow
634.04%
Balance Sheet Health
Assets
6.46%
Debt
8.58%
Book Value per Share
7.74%
Inventory
-35.73%
Shareholder Returns
Dividends per Share
22.93%
Shares Outstanding
-1.01%
Long Term Trends
3Y Revenue/Share
135.72%
5Y Revenue/Share
1,017.28%
3Y Dividend/Share
8.34%
5Y Dividend/Share
-35.74%